Skip to main content

Drug Regimen Compliance: Issues in Clinical Trials and Patient Management

Drug Regimen Compliance: Issues in Clinical Trials and Patient Management

Jean-Michel Métry (Editor), Urs A. Meyer (Editor)

ISBN: 978-0-470-84633-9

Apr 2002

212 pages

Select type: O-Book

Description

Drug Regimen Compliance Issues in Clinical Trials and Patient Management Edited by Jean-Michel Métry Aardex Ltd., Zug, Switzerland and Urs A. Meyer University of Basel, Switzerland A patient's non-compliance with drug regimens can render drugs ineffective. This not only causes problems for the patient but also large costs for health services. Despite a renewed interest in the subject over the past few years, there is still a dearth of new ideas and perspectives. This volume is written in response to this lack, and seeks to:
* Address key topics, such as regulatory issues and the role of compliance in clinical care
* Provide pointers for trials
* Provide guidelines for the management of patients
* Explore means by which compliance can be monitored
* Suggest the best ways to monitor patient management
Drug Regimen Compliance: Issues in Clinical Trials and Patient Management provides the basis for future steps in improving patient compliance and will be invaluable to pharmacologists, toxicologists, pharmaco-epidemiologists, clinical trial scientists, medical economists and all those prescribing drug regimens.
Clinical Trials.

Methodology.

Biostatistics and Trial Design.

Phase II to IV.

Audit and QA.

Regulatory Patient Management.

Outcomes Research/Economics/Pharmacoepidemiology.

Individualism of Treatment/Pharmaco-Vigilance.

Marketing Aspects/Optimisation of Treatment.

Interactive Packaging.

Could Technology Help?